Literature DB >> 17493500

Anaphylaxis: evidence-based long-term risk reduction in the community.

F Estelle R Simons1.   

Abstract

Anaphylaxis occurs frequently in the community, and it can be fatal in community settings. Risk assessment and risk reduction should ideally be coordinated by an allergy/immunology specialist and focus on: (1) prevention of subsequent anaphylaxis episodes, (2) emergency preparedness, and (3) anaphylaxis education. Preventive strategies should include trigger avoidance, specific preventive measures, and optimal management of comorbidities. Despite best efforts to avoid anaphylaxis triggers they can be encountered inadvertently, and anaphylaxis episodes can and do recur. Risk reduction therefore also focuses on emergency preparedness: carrying self-injectable epinephrine, having a personalized Anaphylaxis Emergency Action Plan, and wearing accurate medical identification. Anaphylaxis education should involve not only at-risk individuals and their families, but also health care professionals and the general public.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17493500     DOI: 10.1016/j.iac.2007.03.007

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN: 0889-8561            Impact factor:   3.479


  3 in total

1.  Emergency treatment of anaphylaxis.

Authors:  F Estelle R Simons
Journal:  BMJ       Date:  2008-05-24

2.  Long-term effectiveness of online anaphylaxis education for pharmacists.

Authors:  Sandra M Salter; Sandra Vale; Frank M Sanfilippo; Richard Loh; Rhonda M Clifford
Journal:  Am J Pharm Educ       Date:  2014-09-15       Impact factor: 2.047

3.  Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel.

Authors:  Joshua A Boyce; Amal Assa'ad; A Wesley Burks; Stacie M Jones; Hugh A Sampson; Robert A Wood; Marshall Plaut; Susan F Cooper; Matthew J Fenton; S Hasan Arshad; Sami L Bahna; Lisa A Beck; Carol Byrd-Bredbenner; Carlos A Camargo; Lawrence Eichenfield; Glenn T Furuta; Jon M Hanifin; Carol Jones; Monica Kraft; Bruce D Levy; Phil Lieberman; Stefano Luccioli; Kathleen M McCall; Lynda C Schneider; Ronald A Simon; F Estelle R Simons; Stephen J Teach; Barbara P Yawn; Julie M Schwaninger
Journal:  J Allergy Clin Immunol       Date:  2010-12       Impact factor: 10.793

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.